Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of parkinsonian type multiple system atrophy from Parkinson's disease

European Journal of Neurology

Volumn 15, Issue 10, 2008, Pages 1043-1049

  Kwon, K Y ^a   Choi, C G ^a   Kim, J S ^a   Lee, M C ^a   Chung, S J ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Magnetic resonance imaging; Parkinson's disease; Parkinsonian type multiple system atrophy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CEREBELLUM; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PONS; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD;

EID: 51349142727     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02235.x     Document Type: Article

References (33)

1. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clinical Autonomic Research 1998 8 : 359 362.
2. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994 4 : 835 845.
3. Konagaya M, Konagaya Y, Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. Journal of Neurology, Neurosurgery and Psychiatry 1994 57 : 1528 1531.
4. Lee EA, Cho HI, Kim SS, Lee WY. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism & Related Disorders 2004 10 : 363 368.
5. Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. Journal of Neurology, Neurosurgery and Psychiatry 1998 65 : 65 71.
6. Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002 125 : 1070 1083.
7. Minnerop M, Specht K, Ruhlmann J, et al. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy - a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 2007 36 : 1086 1095.
8. Specht K, Minnerop M, Muller-Hubenthal J, Klockgether T. Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxel-based morphometry and voxel-based relaxometry. Neuroimage 2005 25 : 287 293.
9. Schocke MF, Seppi K, Esterhammer R, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002 58 : 575 580.
10. Seppi K, Schocke MF, Mair KJ, et al. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 2006 31 : 240 245.
11. Seppi K, Schocke MF, Prennschuetz-Schuetzenau K, et al. Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Movement Disorders 2006 21 : 847 852.
12. Kraft E, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002 59 : 1265 1267.
13. Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Archives of Neurology 2002 59 : 835 842.
14. Kraft E, Schwarz J, Trenkwalder C, Vogl T, Pfluger T, Oertel WH. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Archives of Neurology 1999 56 : 225 228.
15. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000 54 : 697 702.
16. Horimoto Y, Aiba I, Yasuda T, et al. Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course? Journal of Neurology 2002 249 : 847 854.
17. Otsuka M, Ichiya Y, Kuwabara Y, et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. Journal of the Neurological Sciences 1996 144 : 77 83.
18. Taniwaki T, Nakagawa M, Yamada T, et al. Cerebral metabolic changes in early multiple system atrophy: a PET study. Journal of the Neurological Sciences 2002 200 : 79 84.
19. Juh R, Kim J, Moon D, Choe B, Suh T. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. European Journal of Radiology 2004 51 : 223 233.
20. Juh R, Pae CU, Lee CU, et al. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Neuroscience Research 2005 52 : 211 219.
21. Otsuka M, Kuwabara Y, Ichiya Y, et al. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG. Annals of Nuclear Medicine 1997 11 : 251 257.
22. Kwon KY, Choi CG, Kim JS, Lee MC, Chung SJ. Comparison of brain MRI and (18)F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Movement Disorders 2007 22 : 2352 2358.
23. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry 1992 55 : 181 184.
24. Antonini A, Leenders KL, Vontobel P, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997 12 : 2187 2195.
25. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005 26 : 912 921.
26. Savoiardo M, Strada L, Girotti F, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990 174 : 693 696.
27. Eidelberg D, Takikawa S, Moeller JR, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Annals of Neurology 1993 33 : 518 527.
28. De Volder AG, Francart J, Laterre C, et al. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Annals of Neurology 1989 26 : 239 247.
29. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. Journal of Neurology, Neurosurgery and Psychiatry 2002 73 : 517 523.
30. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004 127 : 2657 2671.
31. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Movement Disorders 1997 12 : 133 147.
32. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Canadian Journal of Neurological Sciences 1991 18 : 275 278.
33. Righini A, Antonini A, Ferrarini M, et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. Journal of Computer Assisted Tomography 2002 26 : 266 271.